As both CD4+ and CD8+ T cell responses are believed to be beneficial for tumour clearance, it could be advantageous to include HLA‐I‐redirected CD4+ T cells in adoptive cell transfer regimens in addition to CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.